Pulmonary agenesis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:984Q33.3
Who is this for?
Show terms as
5Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pulmonary agenesis is a rare congenital malformation characterized by the complete absence of one or both lungs, including the bronchus, pulmonary vasculature, and lung parenchyma. It is also referred to as lung agenesis. This condition results from a failure of the lung bud to develop during early embryonic life, typically around the fourth to fifth week of gestation. Pulmonary agenesis may be unilateral (affecting one lung) or bilateral (affecting both lungs). Bilateral pulmonary agenesis is incompatible with life. Unilateral pulmonary agenesis, while more survivable, can still present with significant morbidity depending on associated anomalies and the degree of compensatory growth of the remaining lung. Unilateral pulmonary agenesis primarily affects the respiratory system but may also be associated with congenital anomalies involving the cardiovascular, gastrointestinal, genitourinary, and musculoskeletal systems. Key clinical features include respiratory distress, recurrent respiratory infections, reduced exercise tolerance, and mediastinal shift toward the affected side. Some patients may remain relatively asymptomatic if the contralateral lung undergoes adequate compensatory hyperplasia. The condition is more commonly reported on the left side, and right-sided agenesis tends to carry a worse prognosis due to greater mediastinal shift and potential compression of the airways and great vessels. Diagnosis is typically made through imaging studies including chest X-ray, CT scan, and bronchoscopy, which confirm the absence of the lung and its bronchus. Prenatal diagnosis via ultrasound or fetal MRI is also possible. There is no curative treatment for pulmonary agenesis. Management is supportive and focuses on preventing and treating respiratory infections, managing associated anomalies, and monitoring respiratory function. In some cases, surgical intervention may be needed to address airway compression or cardiovascular complications. Long-term follow-up with a multidisciplinary team including pulmonologists, cardiologists, and surgeons is recommended.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Pulmonary agenesis.

View clinical trials →

No actively recruiting trials found for Pulmonary agenesis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Pulmonary agenesis community →

Specialists

5 foundView all specialists →
MM
Mauro Schenone, MD
ROCHESTER, MN
Specialist
PI on 4 active trials
AM
Antoine VALERI, MD,PhD
NEW YORK, NY
Specialist
PI on 1 active trial
LS
Laurent Servais
Specialist
PI on 1 active trial28 Pulmonary agenesis publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pulmonary agenesis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pulmonary agenesisForum →

No community posts yet. Be the first to share your experience with Pulmonary agenesis.

Start the conversation →

Latest news about Pulmonary agenesis

No recent news articles for Pulmonary agenesis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Pulmonary agenesis

What is Pulmonary agenesis?

Pulmonary agenesis is a rare congenital malformation characterized by the complete absence of one or both lungs, including the bronchus, pulmonary vasculature, and lung parenchyma. It is also referred to as lung agenesis. This condition results from a failure of the lung bud to develop during early embryonic life, typically around the fourth to fifth week of gestation. Pulmonary agenesis may be unilateral (affecting one lung) or bilateral (affecting both lungs). Bilateral pulmonary agenesis is incompatible with life. Unilateral pulmonary agenesis, while more survivable, can still present with

How is Pulmonary agenesis inherited?

Pulmonary agenesis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Pulmonary agenesis typically begin?

Typical onset of Pulmonary agenesis is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Pulmonary agenesis?

5 specialists and care centers treating Pulmonary agenesis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.